Investor Relations We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology. Email Alerts Investors: Overview Press Releases Events and Presentations Financials & Filings Stock Information Investor FAQs Contact Us Events Presentations Canaccord Genuity 39th Annual Growth Conference Thursday, August 8, 2019 1:00pm EDT Listen to the Webcast